malondialdehyde has been researched along with Neointima in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Hui, F; Li, Y; Liu, X; Meng, R; Si, J; Yang, B | 1 |
1 other study(ies) available for malondialdehyde and Neointima
| Article | Year |
|---|---|
Linagliptin protects rat carotid artery from balloon injury and activates the NRF2 antioxidant pathway.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Animals; Carotid Arteries; Carotid Artery Injuries; Coronary Restenosis; Cytokines; Dipeptidyl-Peptidase IV Inhibitors; Glutathione Peroxidase; Inflammation Mediators; Linagliptin; Male; Malondialdehyde; Neointima; NF-E2-Related Factor 2; Oxidative Stress; Rats, Wistar; Superoxide Dismutase; Up-Regulation | 2019 |